Azilsartan Medoxomil in the Treatment of Essential Hypertension and Type 2 Diabetes in Asia

Clinical trial NCT02517866 · COMPLETED

Trial details

NCT number: NCT02517866
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Essential Hypertension Type 2 Diabetes Mellitus

Start date: 2015-07-13
Primary completion: 2016-11-15
Enrollment: 380

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.